Abstract
Dicer and Argonaute2 (Ago2) are critical components responsible not only for RNA interference but also for microRNA synthesis. The present study investigated the roles of Dicer and Ago2 in prostate cancer (Pca). First, the expression levels of Dicer and Ago2 in Pca tissues were determined by immunohistochemistry (IHC) and compared with pathological features. Next, RNA interference was used to down-regulate the expression levels of Dicer and Ago2 in the Pca cell lines LNCaP, PC-3, and DU145, and effects on proliferation, apoptosis, and cell cycle were detected using the CCK-8 assay and flow cytometry, respectively. We found that Dicer and Ago2 expression levels in Pca tissues were higher than those in adjacent benign tissues and correlated with lower Gleason patterns, with the exception of Dicer expression in localized Pca. In vitro, silencing Dicer or Ago2 inhibited cell proliferation and induced apoptosis in LNCaP, PC-3, and DU145, as well as arrested the cell cycle at the G2/M phase in androgen-dependent LNCaP, or at S phase in the androgen-independent PC-3 and DU145. Altogether these findings suggest that Dicer and Ago2 play important roles in proliferation, apoptosis, and the cell cycle in Pca and might serve as both promising biomarkers for Pca progression and potential therapeutic targets.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61:1079–92.
Sakurai K, Amarzguioui M, Kim D-H, Alluin J, Heale B, Song M-s, et al. A role for human dicer in pre-RISC loading of siRNAs. Nucleic acids research. 2011;39:1510–25.
Kala R, Peek G, Hardy T, Tollefsbol T. MicroRNAs: an emerging science in cancer epigenetics. Journal of Clinical Bioinformatics. 2013;3:6.
Peters L, Meister G. Argonaute proteins: mediators of RNA silencing. Molecular Cell. 2007;26:611–23.
Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol. 2009;10:126–39.
Papachristou D, Korpetinou A, Giannopoulou E, Antonacopoulou A, Papadaki H, Grivas P, et al. Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas. Virchows Archiv : an international journal of pathology. 2011;459:431–40.
Papachristou D, Sklirou E, Corradi D, Grassani C, Kontogeorgakos V, Rao U. Immunohistochemical analysis of the endoribonucleases Drosha, Dicer and Ago2 in smooth muscle tumours of soft tissues. Histopathology. 2012;60:36.
Faggad A, Kasajima A, Weichert W, Stenzinger A, Elwali N. Dietel M, et al. Histopathology: Down-regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer; 2012.
Khoshnaw S, Rakha E, Abdel-Fatah T, Nolan C, Hodi Z, Macmillan D, et al. Loss of Dicer expression is associated with breast cancer progression and recurrence. Breast Cancer Research and Treatment. 2012;135:403–13.
Zhang B, Chen H, Zhang L, Dakhova O, Zhang Y, Lewis MT, et al. A dosage-dependent pleiotropic role of Dicer in prostate cancer growth and metastasis. Oncogene. 2014;33:3099–108.
Zhang X, Graves P, Zeng Y. Overexpression of human argonaute2 inhibits cell and tumor growth. Biochimica et Biophysica Acta. 1830;2012:2553–61.
Shi TY, Yang G, Tu XY, Yang JM, Qian J, Wu XH, et al. Rad52 variants predict platinum resistance and prognosis of cervical cancer. PLoS One. 2012;7:e50461.
Chiosea S, Jelezcova E, Chandran U, Acquafondata M, McHale T, Sobol R, et al. Up-regulation of Dicer, a component of the microRNA machinery, in prostate adenocarcinoma. The American Journal of Pathology. 2006;169:1812–20.
Yoo N, Hur S, Kim M, Lee J, Lee S. Immunohistochemical analysis of RNA-induced silencing complex-related proteins ago2 and tnrc6a in prostate and esophageal cancers. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica. 2010;118:271–6.
Boyd L, Mao X, Lu Y-J. The complexity of prostate cancer: genomic alterations and heterogeneity. Nature Reviews Urology. 2012;9:652–64.
Gregory RI, Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res. 2005;65:3509–12.
Croce CM, Calin GA. MiRNAs, cancer, and stem cell division. Cell. 2005;122:6–7.
Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006;103:2257–61.
Oh YK, Park TG. SiRNA delivery systems for cancer treatment. Adv Drug Deliv Rev. 2009;61:850–62.
Han L, Zhang A, Zhou X, Xu P, Wang G-X, Pu P-Y, et al. Downregulation of Dicer enhances tumor cell proliferation and invasion. International Journal of Oncology. 2010;37:299–305.
Bai Y, Qiu G-R, Zhou F, Gong L-Y, Gao F, Sun K-L. Overexpression of Dicer1 induced by the upregulation of gata1 contributes to the proliferation and apoptosis of leukemia cells. International Journal of Oncology. 2013;42:1317–24.
Naoghare P, Tak Y, Kim M, Han E, Song J. Knock-down of argonaute 2 (ago2) induces apoptosis in myeloid leukaemia cells and inhibits siRNA-mediated silencing of transfected oncogenes in hek-293 cells. Basic & Clinical Pharmacology & Toxicology. 2011;109:274–82.
Asai T, Suzuki Y, Matsushita S, Yonezawa S, Yokota J, Katanasaka Y, et al. Disappearance of the angiogenic potential of endothelial cells caused by argonaute2 knockdown. Biochemical and Biophysical Research Communications. 2008;368:243–8.
McLoughlin H, Fineberg S, Ghosh L, Tecedor L, Davidson B. Dicer is required for proliferation, viability, migration and differentiation in corticoneurogenesis. Neuroscience. 2012;223:285–95.
Narayanan R, Jiang J, Gusev Y, Jones A, Kearbey J, Miller D, et al. MicroRNAs are mediators of androgen action in prostate and muscle. PloS One. 2010. doi:10.1371/journal.pone.0013637.
Carthew R, Sontheimer E. Origins and mechanisms of miRNAs and siRNAs. Cell. 2009;136:642–55.
Koscianska E, Starega-Roslan J, Krzyzosiak W. The role of Dicer protein partners in the processing of microRNA precursors. PloS one 2011;6
Acknowledgments
This study was supported in part by grants from the National Natural Science Foundation of China (No. 81272837) and the Advanced Technology Foundation of Shanghai Hospitals (SHDC12013122).
Conflicts of interest
None
Author information
Authors and Affiliations
Corresponding author
Additional information
**ao-Jie Bian and Gui-Ming Zhang contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(GIF 109 kb)
Rights and permissions
About this article
Cite this article
Bian, XJ., Zhang, GM., Gu, CY. et al. Down-regulation of Dicer and Ago2 is associated with cell proliferation and apoptosis in prostate cancer. Tumor Biol. 35, 11571–11578 (2014). https://doi.org/10.1007/s13277-014-2462-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13277-014-2462-3